Create Account | Sign In: Author or Forum

Search Symptoms

Doctors Lounge - Pharmacy Articles

Robert L. Coleman, MD's avatar

Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial

Author: Robert L. Coleman, MD
Submitted: September 12, 2017. Updated: September 12, 2017.
Category: Gynecology | Oncology | Pharmacy | Research

Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice… Read more... (Comments: 0)

Ted Lain, MD's avatar

Investigational Topical Minocycline Gel for Acne Advances to Phase III Development

Author: Ted Lain, MD
Submitted: May 25, 2017. Updated: May 25, 2017.
Category: Dermatology | Family Medicine | Internal Medicine | Pharmacy | Research

Clinical trial investigator Dr. Ted Lain comments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory… Read more... (Comments: 0)

Dr. Alberto De la Guerra's avatar

Bevacizumab for breast cancer: FDA grants a stay of execution

Author: Dr. Alberto De la Guerra
Submitted: January 19, 2011. Updated: January 26, 2011.
Category: Gynecology | Oncology | Pharmacy | Research | Surgery

The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence… Read more... (Comments: 0)

Tamer M. Fouad, M.D.'s avatar

Improved survival in AML with higher anthracycline doses

Author: Tamer M. Fouad, M.D.
Submitted: September 29, 2009. Updated: November 24, 2014.
Category: Hematology | Bone Marrow Transplantation | Oncology | Pharmacy

Younger patients with acute myeloid leukemia (AML) that receive higher doses of anthracyclines during induction chemotherapy are reported to have better complete remission rates in most studies. As of yet, studies have failed to show an improved surivival… Read more... (Comments: 0)

Jeffrey A. Gordon, M.D.'s avatar

Aspirin Use as Treatment in Colorectal Cancer: Teaching an Old Dog New Tricks

Author: Jeffrey A. Gordon, M.D.
Submitted: September 12, 2009. Updated: November 24, 2014.
Category: Gastroenterology | Oncology | Pharmacy

Aspirin use can decrease the risk of colorectal adenomas.  Full-dose, but not low-dose, aspirin may decrease the risk of developing colorectal cancer.  Whether or not aspirin use can favorably augment survival in patients diagnosed with colorectal cancer… Read more... (Comments: 7)

Dr. K. Eisele's avatar

Antidepressants do they work? A Review of the Review

Author: Dr. K. Eisele
Submitted: July 27, 2008. Updated: September 21, 2009.
Category: Pharmacy | Psychiatry

This article is in response to an announcement by researchers quoted in many UK publications this week, stating that the class of anti-depressants known as SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors)… Read more... (Comments: 0)

Dr. M. Mavru's avatar

Novel therapy combinations gain ground in treating hepatitis

Author: Dr. M. Mavru
Submitted: May 26, 2006. Updated: September 21, 2009.
Category: Gastroenterology | Hepatology | Pharmacy

According to recent estimates, hepatitis has become a worldwide health problem, affecting millions of people in the U.S. and abroad.

Read more... (Comments: 0)

Dr. Safaa Mahmoud's avatar

Diabetics should receive statins, study says

Author: Dr. Safaa Mahmoud
Submitted: July 01, 2003. Updated: September 21, 2009.
Category: Endocrinology | Diabetes | Pharmacy

Diabetes mellitus is a chronic disease caused by an inherited and/or acquired deficiency in production of insulin by the pancreas, or by ineffectiveness of the insulin produced. Such a deficiency results in increased concentrations of glucose in the blood,… Read more... (Comments: 0)

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application